SARS-CoV-2 Antibodies
Long-term antibody response differences appear unlikely to explain post-COVID-19 syndrome prevalence. The study measured spike antibodies quantitatively using the Elecsys Anti-SARS-CoV-2 S assay. The study measured nucleocapsid antibodies…
1 sources - 5 claims
Long-term antibody response differences appear unlikely to explain post-COVID-19 syndrome prevalence. The study measured spike antibodies quantitatively using the Elecsys Anti-SARS-CoV-2 S assay. The study measured nucleocapsid antibodies qualitatively using the Elecsys Anti-SARS-CoV-2 assay.